Status:
NOT_YET_RECRUITING
Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Breast Cancer Survivor
Pregnant Women
Eligibility:
FEMALE
Brief Summary
To assess the quality of life for women who were pregnant during their breast cancer treatment.
Detailed Description
Primary Objectives Provide preliminary data to describe the current QOL of breast cancer survivors who received cancer treatment while pregnant. Secondary Objectives Identify the relationship between...
Eligibility Criteria
Inclusion
- Eligibility Criteria
- Female, any current age and any age at diagnosis
- Documented diagnosis of breast cancer during pregnancy
- Documentation of receiving chemotherapy during pregnancy
- Alive with no evidence of disease at time of recruitment
- Able to reach and speak English
- Exclusion Criteria
- Any woman who delayed and received their chemotherapy after delivery.
- Any woman who was diagnosed with breast cancer before or after their pregnancy.
- Any woman whom there is documentation of inability to provide consent in the medical record
Exclusion
Key Trial Info
Start Date :
February 22 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07191496
Start Date
February 22 2026
End Date
June 1 2026
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030